Imperative Care, Inc. announces positive results from the SYMPHONY-PE Trial evaluating Symphony® Thrombectomy System in the ...

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

The Health System Board oversees and governs the subsidies of the Medical Center — including the School of Nursing, School of ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the ...

Pain is always disconcerting regardless of where it occurs, but it can be especially worrisome if it emanates from the left ...

Guam Regional Medical City will be hosting this Saturday a free outreach aimed at raising awareness about lung health, ...

What do they do with the house?' "It would seem that Bernie should just pay 50% of the original price of the house, minus the difference in what they each paid toward the mortgage." (Photo subject is ...

Overall, these data show the prognostic potential for 24 weeks of sotatercept therapy to improve the heart’s right ...

Imperative Care today announced positive efficacy and safety results from its pivotal SYMPHONY-PE thrombectomy system study.

GSK to showcase new research from its broad respiratory portfolio at the European Respiratory Society Congress 2025: London, UK Wednesday, September 17, 2025, 11:00 Hrs [IST] GSK ...

The easiest way to make sure they both get a fair return on their investment would be to sell the house. I'll answer your questions in the order you asked them.

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.